Does drug touted by Trump work on COVID-19? After data debacle, we still don’t know

LONDON (Reuters) – Scientists are resuming COVID-19 trials of the now world-famous drug hydroxychloroquine, as confusion continues to reign about the anti-malarial hailed by U.S. President Donald Trump as a potential “game-changer” in fighting the pandemic. The renewed research push follows widespread criticism of the quality of data in a study published by The Lancet,…

Continue Reading

Convalescent plasma not helpful in China study; hydroxychloroquine doesn’t prevent infection

(Reuters) – The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. Convalescent plasma disappoints in Chinese trial Infusions of antibody-rich blood plasma from people who have recovered from the coronavirus, so-called convalescent…

Continue Reading

Oldest and largest ancient Maya structure found in Mexico

WASHINGTON (Reuters) – Scientists using an aerial remote-sensing method have discovered the largest and oldest-known structure built by the ancient Maya civilization – a colossal rectangular elevated platform built between 1,000 and 800 BC in Mexico’s Tabasco state. The structure, unlike the soaring Maya pyramids at cities like Tikal in Guatemala and Palenque in Mexico…

Continue Reading

France nears 1-billion-euro crisis fund for aero suppliers: sources

PARIS (Reuters) – French government and industry officials are negotiating a 1-billion-euro, privately led investment fund for small aerospace suppliers in which major manufacturers could invest 200 million euros, people familiar with the proposals said on Wednesday. The scheme mirrors government-backed plans in France to help the automobile sector and comes as the aerospace industry…

Continue Reading